<?xml version="1.0" encoding="UTF-8"?>
<p>Multiple targets and inhibitory mechanisms have been proposed for 
 <italic>Flavivirus</italic> proteases so far [
 <xref rid="pone.0223017.ref053" ref-type="bibr">53</xref>, 
 <xref rid="pone.0223017.ref054" ref-type="bibr">54</xref>, 
 <xref rid="pone.0223017.ref067" ref-type="bibr">67</xref>, 
 <xref rid="pone.0223017.ref068" ref-type="bibr">68</xref>], which have provided insightful structural information regarding the NS2B-NS3 catalytic site, helping computational-aided drug design efforts even further. For instance, by solving NS2B-NS3’s tridimensional structure bound to a peptide-like inhibitor, Erbel and coworkers [
 <xref rid="pone.0223017.ref069" ref-type="bibr">69</xref>] provided fundamental information regarding the protease fold, catalytic site structure and inhibition mechanisms. As found by others [
 <xref rid="pone.0223017.ref046" ref-type="bibr">46</xref>, 
 <xref rid="pone.0223017.ref070" ref-type="bibr">70</xref>–
 <xref rid="pone.0223017.ref072" ref-type="bibr">72</xref>], inhibitors often bind to His
 <sup>51</sup> or to nearby residues such as Asp
 <sup>75</sup>, Asp
 <sup>129</sup>, Gly
 <sup>153</sup> and Tyr
 <sup>161</sup> (
 <xref ref-type="supplementary-material" rid="pone.0223017.s002">S1 Fig</xref>), hampering the bond of the substrate to the catalytic site.
</p>
